Do manufacturers of brand-name drugs engage in price competition? An analysis of introductory prices

CMAJ. Canadian Medical Association Journal

Volumn 174, Issue 8, 2006, Pages 1120-1121

  Lexchin, Joel ^a,b,c,d  

^a YORK UNIVERSITY   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG COST; DRUG INDUSTRY; DRUG MARKETING; HEALTH CARE MANAGEMENT; NOTE; PRACTICE GUIDELINE; PROSPECTIVE PRICING; THERAPY EFFECT; WORLD HEALTH ORGANIZATION; ARTICLE; CANADA; COMMERCIAL PHENOMENA; ECONOMIC ASPECT; ECONOMICS; FINANCIAL MANAGEMENT; HUMAN; PATENT; UNITED STATES;

CANADA; COMMERCE; DRUG COSTS; DRUG INDUSTRY; ECONOMIC COMPETITION; HUMANS; MARKETING OF HEALTH SERVICES; PATENTS; UNITED STATES;

EID: 33645928712     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.051687     Document Type: Note

References (12)

1. A review of new drugs in 2004: floundering innovation and increased risk-taking. Prescrire Int 2005;14:68-73.
2. Patented Medicine Prices Review Board (PMPRB). Annual report 2004. Ottawa: PMPRB; 2005.
3. Lee TH. "Me-too" products - Friend or foe? [published erratum in N Engl J Med 2004;350(15):1586]. N Engl J Med 2004;350:211-2.
4. DiMasi JA. Price trends for prescription: pharmaceuticals: 1995-1999. Background report prepared for the US Department of Health and Human Services' Conference on Pharmaceutical Pricing Practices, Utilization and Costs; 2000 Aug 8-9; Washington, DC. Available: http://aspe.hhs.gov/health/reports/Drug-papers/dimassi/dimasi-final.htm (accessed 2006 Mar 6).
5. Lu ZJ, Comanor WS. Strategic pricing of new pharmaceuticals. Rev Econ Stat 1998;80:108-18.
6. Reekie WD. Price and quality competition in the United States drug industry. J Ind Econ 1978;26:223-37.
7. Inter-provincial prescription drug price comparison 1995/96-1999/00. Prepared by the Patented Medicine Prices Review Board for the Federal/Provincial/Territorial Working Group on Drug Prices. Available: www.pmprb-cepmb.gc.ca/CMFiles/comparison-e14HFB-492003-9884.pdf (accessed 2006 Mar 6).
8. Rossi S, editor. Australian medicines handbook. Adelaide: Australian Medicines Handbook Pty Ltd; 2002.
9. Gray J, editor. Therapeutic choices. 4th ed. Ottawa: Canadian Pharmacists Association; 2003.
10. Ekelund M, Persson B. Pharmaceutical pricing in a regulated market. Rev Econ Stat 2003;85:298-306.
11. Federal/Provincial/Territorial Working Group on Drug Prices. Cost driver analysis of provincial drug plans: Ontario 1992/93-1998/99. Ottawa: The Working Group; 2000. Available: www.pmprb-cepmb.gc.ca/CMFiles/on-e14HNL-492003-4413.pdf (accessed 2006 Mar 6).
12. Analysis of drug claim costs 1997-2001. Toronto; Green Shield Canada; 2003.